Am J Perinatol
DOI: 10.1055/a-1792-4535
Original Article

Vertical Transmission of SARS-CoV-2 during Pregnancy: A Prospective Italian Cohort Study

Simonetta Costa
1   Department of Woman and Child Health and Public Health, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
,
2   Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
,
Anthea Bottoni
2   Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
,
Eloisa Tiberi
2   Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
,
Simona Fattore
1   Department of Woman and Child Health and Public Health, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
,
Roberta Pastorino
1   Department of Woman and Child Health and Public Health, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
,
Nicoletta Di Simone
3   Department of Biomedical Sciences, Humanitas University, IRCCS Humanitas Research Hospital, Milan, Italy
,
Antonio Lanzone
1   Department of Woman and Child Health and Public Health, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
,
Danilo Buonsenso
2   Department of Woman and Child Health and Public Health, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
,
Piero Valentini
1   Department of Woman and Child Health and Public Health, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
,
Paola Cattani
1   Department of Woman and Child Health and Public Health, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
,
Rosaria Santangelo
4   Department of Laboratory and Infectivology Science, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of Sacred Heart, Rome, Italy
,
4   Department of Laboratory and Infectivology Science, Fondazione Policlinico Universitario A. Gemelli IRCCS, Catholic University of Sacred Heart, Rome, Italy
,
Giovanni Scambia
1   Department of Woman and Child Health and Public Health, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
,
Giovanni Vento
1   Department of Woman and Child Health and Public Health, Catholic University of Sacred Heart, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome, Italy
› Author Affiliations
Funding None.

Abstract

Objective The extent of vertical transmission (VT) of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) from mothers their fetuses or neonates is still uncertain. We aimed to determine the incidence of VT.

Study Design In this prospective cohort study. All mother diagnosed with SARS-CoV-2 infection at the time of delivery or up to 1 week prior and their neonates, managed in a tertiary referral hospital for pregnancy complicated by coronavirus disease 2019 (COVID-19) in Rome, from April 2 to December 22, 2020, were included. Maternal infection was defined as nasopharyngeal swab test results positive for SARS-CoV-2 reverse transcription-polymerase chain reaction (RT-PCR). Biological samples were collected before, at, and after delivery to test positivity for SARS-CoV-2 RT-PCR and anti-SARS-CoV-2-specific antibodies.

Results The cohort included 95 women and 96 neonates with documented SARS-CoV-2 test results. Four neonates (4.2%) tested positive. The incidence of VT, according to the guidance criteria for diagnosing perinatal SARS-CoV-2 infection, was 5.2%. Neonatal symptoms were due to prematurity or fetal distress: symptomatic infants had lower median (min–max) gestational age, 38.1 (29.3–40.6) versus 39.3 (33.9–41.9) weeks (p = 0.036), and 1-minute and 5-minute Apgar scores, 9 (3–9) versus 9 (7–10) (p = 0.036) and 10 (6–10) versus 10 (8–10) (p = 0.012), respectively, than asymptomatic infants and needed more frequent assistance in the delivery room (22.2 vs 2.5%; p = 0.008). Only six (7.1%) neonates had anti-SARS-CoV-2-specific antibodies, despite the ongoing maternal infection.

Conclusion The incidence of VT is low as is the detection of specific anti-SARS-CoV-2 antibodies in cord blood when infection is contracted late in pregnancy. This would suggest poor protection of infants against horizontal transmission of the virus.

Key Points

  • VT of SARS-CoV-2 from pregnant mothers to fetuses or neonates can be possible.

  • In this prospective cohort study, the incidence of VT is found to be 5.2%.

  • VT is low but exists.

Author Contributions

All the authors had a substantial contribution to the conception of the work, the acquisition and analysis of data for the work, and final approval of the version to be published. All the authors agreed to be accountable for all aspects of the work. S. C. and L. G. had full access to all of the data in the study and take responsibility for the integrity of the data and the accuracy of the data analysis. S. C., L. G., A. B., P. C., D. B., A. L., N. D. S., G. V. were involved with the concept and design. S. C., L. G., E. T., P. C., N. D. S. were involved with acquisition, analysis, or interpretation of data. The drafting of the manuscript is done by S. C., L. G., A. B., P. C. while S. C., L. G., P. C. are responsible for critical revision of the manuscript for important intellectual content and the statistical analysis is done by S. C., S. F.




Publication History

Received: 15 September 2021

Accepted: 04 March 2022

Accepted Manuscript online:
09 March 2022

Article published online:
17 May 2022

© 2022. Thieme. All rights reserved.

Thieme Medical Publishers, Inc.
333 Seventh Avenue, 18th Floor, New York, NY 10001, USA

 
  • References

  • 1 Chen H, Guo J, Wang C. et al. Clinical characteristics and intrauterine vertical transmission potential of COVID-19 infection in nine pregnant women: a retrospective review of medical records. [published correction appears in Lancet. 2020 Mar 28;395(10229):1038] Lancet 2020;395(10226): 809-815
  • 2 Dumitriu D, Emeruwa UN, Hanft E. et al. Outcomes of neonates born to mothers with severe acute respiratory syndrome coronavirus 2 infection at a large medical center in New York City. JAMA Pediatr 2021; 175 (02) 157-167
  • 3 Tolu LB, Ezeh A, Feyissa GT. Vertical transmission of severe acute respiratory syndrome coronavirus 2: a scoping review. PLoS One 2021; 16 (04) e0250196
  • 4 Kotlyar AM, Grechukhina O, Chen A. et al. Vertical transmission of coronavirus disease 2019: a systematic review and meta-analysis. Am J Obstet Gynecol 2021; 224 (01) 35-53 .e3
  • 5 Lopes de Sousa ÁF, Carvalho HEF, Oliveira LB. et al. Effects of COVID-19 infection during pregnancy and neonatal prognosis: what is the evidence?. Int J Environ Res Public Health 2020; 17 (11) 4176
  • 6 Ashraf MA, Keshavarz P, Hosseinpour P. et al. Coronavirus disease 2019 (COVID-19): a systematic review of pregnancy and the possibility of vertical transmission. J Reprod Infertil 2020; 21 (03) 157-168
  • 7 Dube R, Kar SS. COVID-19 in pregnancy: the foetal perspective-a systematic review. BMJ Paediatr Open 2020; 4 (01) e000859
  • 8 Trippella G, Ciarcià M, Ferrari M. et al. COVID-19 in pregnant women and neonates: a systematic review of the literature with quality assessment of the studies. Pathogens 2020; 9 (06) 485
  • 9 Di Toro F, Gjoka M, Di Lorenzo G. et al. Impact of COVID-19 on maternal and neonatal outcomes: a systematic review and meta-analysis. Clin Microbiol Infect 2021; 27 (01) 36-46
  • 10 Muhidin S, Behboodi Moghadam Z, Vizheh M. Analysis Of Maternal Coronavirus Infections And Neonates Born To Mothers With 2019-nCoV; a systematic review. Arch Acad Emerg Med 2020; 8 (01) e49
  • 11 Juan J, Gil MM, Rong Z, Zhang Y, Yang H, Poon LC. Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound Obstet Gynecol 2020; 56 (01) 15-27
  • 12 Akhtar H, Patel C, Abuelgasim E, Harky A. COVID-19 (SARS-CoV-2) infection in pregnancy: a systematic review. Gynecol Obstet Invest 2020; 85 (04) 295-306
  • 13 Zhu H, Wang L, Fang C. et al. Clinical analysis of 10 neonates born to mothers with 2019-nCoV pneumonia. Transl Pediatr 2020; 9 (01) 51-60
  • 14 Wang X, Zhou Z, Zhang J, Zhu F, Tang Y, Shen X. A case of 2019 novel coronavirus in a pregnant woman with preterm delivery. [published correction appears in Clin Infect Dis. 2021 May 4;72(9):1684] Clin Infect Dis 2020; 71 (15) 844-846
  • 15 Schwartz DA. An analysis of 38 pregnant women with COVID-19, their newborn infants, and maternal-fetal transmission of SARS-CoV-2: maternal coronavirus infections and pregnancy outcomes. Arch Pathol Lab Med 2020; 144 (07) 799-805
  • 16 Zeng L, Xia S, Yuan W. et al. Neonatal early-onset infection with SARS-CoV-2 in 33 neonates born to mothers with COVID-19 in Wuhan, China. JAMA Pediatr 2020; 174 (07) 722-725
  • 17 Dong L, Tian J, He S. et al. Possible vertical transmission of SARS-CoV-2 from an infected mother to her newborn. JAMA 2020; 323 (18) 1846-1848
  • 18 Vivanti AJ, Vauloup-Fellous C, Prevot S. et al. Transplacental transmission of SARS-CoV-2 infection. Nat Commun 2020; 11 (01) 3572
  • 19 Correia CR, Marçal M, Vieira F. et al. Congenital SARS-CoV-2 infection in a neonate with severe acute respiratory syndrome. Pediatr Infect Dis J 2020; 39 (12) e439-e443
  • 20 Fenizia C, Biasin M, Cetin I. et al. Analysis of SARS-CoV-2 vertical transmission during pregnancy. Nat Commun 2020; 11 (01) 5128
  • 21 Zaigham M, Holmberg A, Karlberg ML. et al. Intrauterine vertical SARS-CoV-2 infection: a case confirming transplacental transmission followed by divergence of the viral genome. BJOG 2021; 128 (08) 1388-1394
  • 22 Khoury R, Bernstein PS, Debolt C. et al. Characteristics and outcomes of 241 births to women with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection at five New York City medical centers. Obstet Gynecol 2020; 136 (02) 273-282
  • 23 Woodworth KR, Olsen EO, Neelam V. et al; CDC COVID-19 Response Pregnancy and Infant Linked Outcomes Team; COVID-19 Pregnancy and Infant Linked Outcomes Team (PILOT). Birth and infant outcomes following laboratory-confirmed SARS-CoV-2 infection in pregnancy - SET-NET, 16 jurisdictions, March 29-October 14, 2020. MMWR Morb Mortal Wkly Rep 2020; 69 (44) 1635-1640
  • 24 Flaherman VJ, Afshar Y, Boscardin J. et al. Infant outcomes following maternal infection with SARS-CoV-2: first report from the PRIORITY study. Clin Infect Dis 2021; 73 (09) e2810-e2813
  • 25 Carrasco I, Muñoz-Chapuli M, Vigil-Vázquez S. et al. SARS-COV-2 infection in pregnant women and newborns in a Spanish cohort (GESNEO-COVID) during the first wave. BMC Pregnancy Childbirth 2021; 21 (01) 326
  • 26 Shah PS, Diambomba Y, Acharya G, Morris SK, Bitnun A. Classification system and case definition for SARS-CoV-2 infection in pregnant women, fetuses, and neonates. Acta Obstet Gynecol Scand 2020; 99 (05) 565-568
  • 27 Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) reporting guideline.. Available at: https://www.equator-network.org/reporting-guidelines/strobe/
  • 28 Select Statistical Services. Population proportion – sample size.. Available at: https://select-statistics.co.uk/calculators/sample-size-calculator-population-proportion/
  • 29 INTERGROWTH-21st.. Standards and tools. Available at: https://intergrowth21.tghn.org/standards-tools/
  • 30 Pique-Regi R, Romero R, Tarca AL. et al. Does the human placenta express the canonical cell entry mediators for SARS-CoV-2?. eLife 2020; 9: e58716
  • 31 Edlow AG, Li JZ, Collier AY. et al. Assessment of maternal and neonatal SARS-CoV-2 viral load, transplacental antibody transfer, and placental pathology in pregnancies during the COVID-19 pandemic. JAMA Netw Open 2020; 3 (12) e2030455
  • 32 Li M, Chen L, Zhang J, Xiong C, Li X. The SARS-CoV-2 receptor ACE2 expression of maternal-fetal interface and fetal organs by single-cell transcriptome study. PLoS One 2020; 15 (04) e0230295
  • 33 Di Mascio D, Khalil A, Saccone G. et al. Outcome of coronavirus spectrum infections (SARS, MERS, COVID-19) during pregnancy: a systematic review and meta-analysis. Am J Obstet Gynecol MFM 2020; 2 (02) 100107
  • 34 Norman M, Navér L, Söderling J. et al. Association of maternal SARS-CoV-2 infection in pregnancy with neonatal outcomes. JAMA 2021; 325 (20) 2076-2086
  • 35 Atyeo C, Pullen KM, Bordt EA. et al. Compromised SARS-CoV-2-specific placental antibody transfer. Cell 2021; 184 (03) 628-642 .e10
  • 36 Beharier O, Plitman Mayo R, Raz T. et al. Efficient maternal to neonatal transfer of antibodies against SARS-CoV-2 and BNT162b2 mRNA COVID-19 vaccine. J Clin Invest 2021; 131 (13) e150319 . Erratum in: J Clin Invest. 2021 Oct 1;131(19): PMID: 34014840; PMCID: PMC8245182
  • 37 Costa S, Posteraro B, Marchetti S. et al. Excretion of SARS-CoV-2 in human breast milk. Clin Microbiol Infect 2020; 26 (10) 1430-1432
  • 38 Chambers C, Krogstad P, Bertrand K. et al. Evaluation for SARS-CoV-2 in breast milk from 18 infected women. JAMA 2020; 324 (13) 1347-1348
  • 39 Krogstad P, Contreras D, Ng H. et al. No evidence of infectious SARS-CoV-2 in human milk: analysis of a cohort of 110 lactating women. Preprint. Medrxiv 2021
  • 40 Kumar J, Meena J, Yadav A, Kumar P. SARS-CoV-2 detection in human milk: a systematic review. J Matern Fetal Neonatal Med 2021; (e-pub ahead of print). doi: DOI: 10.1080/14767058.2021.1882984.